|
|
Physicians and patients must read the black box warning in the package insert. Because of the risk of fatal aplastic anemia and liver failure, use should be reserved for patients in whom the risk-benefit ratio is favorable.
Patients who are allergic to felbamate or to other carbamates should not take Felbatol. Neither should those who have had any liver disease, blood disorder, or autoimmune disease.
Welcome to the Wiki. This space is created for epilepsy.com members to share their own experiences and expertise to help refine and expand the discussion around important topics.
No members have yet contributed to this topic. If you are not yet an epilepsy.com member, register today to get started on this Wiki topic and the many other advantages of being a member. If you are a member and wish to be the first to edit this Wiki topic, please make sure to login, then click on the orange "Start Wiki" button at the top of this page. Or, learn more about Wikis.
|
What Causes Epilepsy (Epilepsy.com #5)
Postedat10/23/2007 - 12:12pm Epilepsy affects nearly 3 million Americans! But who is really at risk?
|
